Introduction
============

According to the global statistics, cancer as one of the most preventable non-communicable chronic diseases is the second leading cause of death after cardiovascular disease worldwide. To our knowledge, only about 2% of all cancers diagnosed in industrialized nations are childhood malignancies, but despite a low prevalence of cancer in children, it represents the most frequent cause of death among children in developed countries. Based on the epidemiological surveys conducted for mortality, malignancy was second cause of death after accidents in children older than one in the United States \[[@b1-IJCP-05-093]\].On the other hand, in developing countries, childhood cancer mortality may not be the first priority of research and it may seem an unaffordable luxury issue, compared to high mortality rates in other causes, such as infections \[[@b2-IJCP-05-093]\]. However, despite under-reporting, cancer is now the 3rd or 4th cause of death among children in many developing countries \[[@b2-IJCP-05-093]\]. In addition, according to the Montevideo document published by the International Society of Pediatric Oncology (SIOP), almost 70% of childhood cancers are currently curable with adequate treatments.

There are some data showing prevalence and cancer-related mortality in children and adolescents have different epidemiological pattern. However the substantial differences between pediatric and adult malignancies are not just limited to this; other examples emphasizing the need for separate analysis and further research in epidemiology of childhood malignancies are as follow: tumor types and histopathological characteristics, genetic etiology and teratogenic factors in pediatric malignancies, possibility of spontaneous regression towards benign category, and remarkable improvement in the prognosis and advances in management of childhood cancers \[[@b3-IJCP-05-093]\].

Considering that children comprise a considerable proportion of our population, for example 29% of the current population of Iran and also considering geographic and racial differences between Iran and other countries, it is inevitable to do a local epidemiologic research in this field. Early preventive measures and a diagnosis in time, and also appropriate treatments are essential for reducing the rate of pediatric cancers but they need classified demographic data including incidence rate, prevalence, age, gender distribution, etiologies, and prognosis and survival rates.

Another important issue is the temporal trends of childhood malignancies. A brief review indicates that several studies have been conducted to analyze and interpret the patterns and trends of cancer in children. Despite of complications caused by short-term random variation, artificial fluctuations introduced by screening and changes in diagnosis or disease classification as well as completeness of reporting and multiple factors which may affect the risk of developing cancer and progression in specific cancer sites, recent reports suggest an increasing trend for some childhood malignancies which may be worthy of further analysis \[[@b4-IJCP-05-093]-[@b12-IJCP-05-093]\]. Changes in temporal trends in the incidence of particular types of cancer may also reflect changes in exposure to underlying etiologic factors; therefore public health actions are required to address such issues more seriously.

In this hospital-based study, we described the demographics, age and gender distribution for each tumor category; we also analyzed changes in temporal trends of each tumor category during a 15-year period. The results from this study can provide further opportunities for etiologic research and such findings may help for better prevention strategies in the future.

Materials and Methods
=====================

In this descriptive retrospective study, we extensively reviewed the patients\' medical records of younger than 15 years of age with solid malignant tumors, from 1996 to 2010. Due to lack of a comprehensive hospital registration system, we firstly established a complete pediatric cancer registry, using the last version of International Classification of Childhood Cancers (ICCC) diagnostic groups. All 784 patients were finally included in the data set and following variables were collected: name, tissue block number, hospital admission code, age, age group, gender, date of diagnosis, ICCC diagnostic groups, and tumor type and tumor site. All individuals who enrolled in this study had histopathological proven solid malignant tumors confirmed by two pediatric pathologists and if the diagnosis was uncertain, they evaluated the case by a further immunohistochemistry assay. As ICCC was not available before 2000, two pediatric pathologists revised the data collected before it and reviewed the slides and necessary modifications were implemented to fulfil the updated criteria. After being assessed for eligibility some groups were excluded: patients older than 15 years as the hospital insurance policy didn't cover these patients and having this group could be counted as a remarkable underestimation. Manual checking for duplicate records were performed by comparing names, age, gender, date and kind of diagnosis. All duplicate cases whether due to recurrence or follow up were excluded. All patients with missing data or uncertain diagnosis were also excluded.

**Statistical Analysis**

Statistical analyses were performed using SPSS version 11. For categorical variables Chi-square test was used. P-values were based on two-sided tests and the cut-off point for statistical significance was P\<0.05.

Results
=======

As mentioned before, 784 solid malignant tumors were classified according to the ICCC diagnostic categories. Frequency of the tumors classifications were as follows: 1. Lymphoma and reticuloendothelial neoplasm 186 (23.7%), 2- CNS and miscellaneous intracranial and intraspinal neoplasm 175 (22.3%), 3-Sympathetic Nervous System tumor (SNS tumors)131(16.7%), 4 and 5- Soft-tissue sarcoma and renal tumors both 84(10.7%), 6-Germ-cell, trophoblastic and other gonadal neoplasm 44(5.6%), 7-Hepatic tumors 40(5.1%),8- Other cancers and miscellaneous categories 34(4.3%), 9-Malignant bone tumors 6(0.8%). Changes in overall frequency of solid malignant tumors in a 15-year period are shown in [Figure 1](#f1-IJCP-05-093){ref-type="fig"}.

**Gender Distribution**

Amongst 784 cases, 329 (42%) were female and 455(58%) were male, with a 1.38 male to female ratio. The gender distribution was almost the same in the first two the age groups. Male to female ratio was 1.16 in less than one year and 1.12 in 1-4 year old group. However, such trend turned towards more male dominancy in the older age groups i.e. 1.69 male to female ratio in 5-9 age group and 1.93 in 10-14 year old age group. For both sexes the most frequent cases were in 1-4 year old group (48% of females vs. 38.9% of males).The difference in distribution of genders in different age groups was statistically significant using Chi-square test (P-value\<0.05). You can see further details in [Figure 2](#f2-IJCP-05-093){ref-type="fig"}.

**Age Distribution**

Among 784 cases, 91(11.6%) were below 1 year old, 335 (42.7%) were in 1-4 age group, 229 (29.2%) were in 5-9 age group and 129(16.5%) of cases were in 10-14 age group. The pattern of age distribution was similar in the most of the 15 year period, with some exceptions in some years i.e. the 5-9 was the leading age group ([Figure 3](#f3-IJCP-05-093){ref-type="fig"}).

In children below 1 and 1-4 year old of age, SNS tumors with 30 (33%) and 75(22.4%) of cases were respectively the most frequent tumor category while in 5-9 and 10-14 year old group, lymphomas and reticuloendothelial neoplasms were the most with 87(38%) and 60(46.5%) of cases respectively. CNS tumors were the second most common tumor in overall and also in each age category. The peak age of diagnosis for almost all tumor categories was 1-4 year old. These categories included: CNS tumors, sympathetic nervous system tumors, hepatic and renal tumors, soft tissue sarcomas, and germ-cell tumors. The peak age of incidence in contrast to other categories was 5-9 year old for lymphomas and 10-14 year old for bone tumors. More details in frequency and distribution of each tumor category in different age groups are listed in [Table1](#t1-IJCP-05-093){ref-type="table"} and shown in [Figure 3](#f3-IJCP-05-093){ref-type="fig"}.

**Tumor Specific Age-gender Distribution**:

In male the four most common tumors were 1- Lymphomas and reticuloendothelial neoplasms 143(31.4%) 2-CNS tumors 98(21.5%), 3-SNS tumors 65(14.3%) and 4-Renal tumors 53(11.6%). In female the four most common tumors were 1- CNS tumors 77(23.4%), 2- SNS tumors 66(20.1%), 3-Lymphomas and reticuloendothelial neoplasms 43(13.1%) and 4-Soft tissue sarcomas 42(12.8%).

The overall pattern of male dominancy was observed in the following tumor categories: 1- Lymphomas and reticuloendothelial neoplasms, 2-Renal tumors, 3-Hepatic tumors, 4- CNS tumors. Only germ-cell tumors were more frequent among females. On the other hand, the frequency of some tumors such as SNS tumors, soft tissue sarcomas and bone tumors were relatively similar among male and female. The frequency and distribution of each tumor category in male and female have also been illustrated in [Table 2](#t2-IJCP-05-093){ref-type="table"}.

**Analyzing the Trend in More Details**

We assessed the trend of each tumor category separately; however, we only analyzed the trend of the three most frequent categories in different sex and age groups in the 15 year study period. The results are shown in [Figures 4](#f4-IJCP-05-093){ref-type="fig"}-[](#f5-IJCP-05-093){ref-type="fig"}[](#f6-IJCP-05-093){ref-type="fig"}[](#f7-IJCP-05-093){ref-type="fig"}[](#f8-IJCP-05-093){ref-type="fig"}[9](#f9-IJCP-05-093){ref-type="fig"}.

Discussion
==========

We classified the solid childhood malignancies using the ICCC diagnostic categories. Previous national reports suggested that the incidence of childhood cancer in Iran is significantly lower than the developed countries; such difference was attributed to a possible under reporting due to differences in diagnostic and registration process, in addition to the different environmental exposure and genetic background \[[@b13-IJCP-05-093]-[@b17-IJCP-05-093]\].

According to epidemiologic studies, the three most common cancers in children are leukemia, CNS tumors and lymphomas; these cancers are followed by SNS tumors, soft tissue sarcomas and renal tumors in order of frequency. Such pattern is observed in the United States, Europe and Africa; however, in South America, there is a difference pattern of cancer distribution so that the most prevalent malignancies in children are leukemia, lymphomas and brain and CNS tumors \[[@b13-IJCP-05-093], [@b17-IJCP-05-093]\]. According to the epidemiologic surveys conducted in Iran, the difference in pattern also is in compliance with our population \[[@b16-IJCP-05-093]\]. Except leukemia, the order of frequency was similar to the national study mentioned above. Lymphomas and CNS tumors are the most common followed by SNS tumors, soft tissue sarcomas and renal tumors. It is worth mentioning that variation in incidence of CNS tumors have attributed to the difference in registration process throughout the world; such difference is more pronounced in registration of non-malignant CNS tumors and tumors of uncertain behavior\[[@b18-IJCP-05-093]\].

**Age Distribution**

Though this pattern varies by tumor categories, the peak age of diagnosis of overall solid malignancies was 1-4 year old in our study; such pattern has also been reported by Surveillance, Epidemiology and End Results (SEER) program in the USA and UK cancer research centers. In a tumor specific analysis, we found that for almost all tumor categories, except lymphomas and bone tumors, the peak age of presentation was 1-4 year old. For lymphomas we observed a significant increase of cases in 5-9 and 10-14 age groups while the number of cases below 2 years was considerably low. Very few cases of orthopedic malignancies had been admitted to our hospital because it was not a center for pediatric orthopedics. Although few cases of bone tumors included in our study, but most cases were in 10-14 year old group. These findings also match SEER and UK statistics \[[@b14-IJCP-05-093], [@b19-IJCP-05-093]\].

**Gender Distribution**

Generally, the overall incidence of malignancies in boys is higher than girls \[[@b20-IJCP-05-093]\]. In our hospital based study the overall male to female ratio was 1.38. In infants, this ratio was 1.16 while in older age groups i.e. 1-4, 5-9, 10-14 the ratio was 1.12, 1.69 and 1.93 respectively, with a trend towards more significant male dominancy. The difference observed in distribution of genders in different age groups, as mentioned before, was statistically significant (P-value\<0.05). Further details are also demonstrated in [Figure 2](#f2-IJCP-05-093){ref-type="fig"}.This finding is in compliance with statistics reported by SEER program which refers to infancy as a "notable period" ,the only age group in which female rate of malignancy is not lower than male \[[@b21-IJCP-05-093]\]. When we analyzed the gender distribution for each tumor category, our findings mostly matched the statistics reported by cancer research in the United Kingdom. Similar to our survey, they reported almost equal distribution of cases in different sexes, for tumors such as SNS tumors, bone tumors and miscellaneous tumors. Germ cell tumors were the only type of tumors that we observed more in female cases than men. Other tumor categories were similar to their male dominant pattern. The only tumor category in which the findings contrasted the UK reports significantly, was the renal tumors in which we had considerable male dominancy while in the report from UK there was a female dominancy in the renal tumors. We also further analyzed gender distribution in each category, across different age groups, to unmask some epidemiological patterns that might be possibly missed in general assessment. For instance, we discovered a notable female dominancy in 1-4 year old group, for SNS tumors, soft tissue sarcomas and germ cell tumors in our study.

**Trend**

We observed a drastic change in trend of childhood solid malignancies, as you can see in the [Figure1](#f1-IJCP-05-093){ref-type="fig"}. The total number of cases almost doubled from 2009 (54(6.9%)) to 2010 (96(12.2%)). Such trend was particularly detected in CNS and SNS tumor categories. Moreover, when we divided CNS tumors into two subcategories, one consisting of all malignant CNS tumors plus tumors with uncertain behavior like astrocytoma and the other group consisting of only malignant CNS tumors, the change in trend was more significant. 8 cases were observed (14.28% relative frequency in 2009) versus 22 cases (22.9% relative frequency in 2010) in the only malignant category comparing to 14 cases (25% relative frequency in 2009) versus 27 cases (28.12% relative frequency in 2010) in malignant plus uncertain group, showing that the only malignant CNS tumors had played a more pronounced role in the increasing pattern of overall trend in 2010 and tumors with uncertain behavior didn't contribute. More details and 15 year trend are shown in [Figures1](#f1-IJCP-05-093){ref-type="fig"}0 and 11.

Other studies on epidemiology of childhood cancers have reported significant increases of incidence statistically. Such rise is partly attributed to the improvement of diagnostic capabilities and more accurate registration of cases worldwide; however, the theories on the changes of risk factors should be interpreted in this context \[[@b5-IJCP-05-093], [@b22-IJCP-05-093]-[@b25-IJCP-05-093]\].

**Strengths and Limitations**

***Limitations***

The findings in this report are subject to at least four noteworthy limitations:

1.  Despite the fact that Mofid Children Hospital is one of the largest referral pediatric centers in Iran, our sample might have some biased result and might not be the best representative of the general population.

2.  The hospital's insurance policy didn't cover the adolescent population, therefore, we had to exclude 15-19 year old age group.

3.  The children with malignancies such as leukemia are usually admitted to other specialty centers. In order to prevent under reporting, despite of having considerable number of them in our hospital, we had to exclude them and limit our study only to the solid malignancies; we excluded retinoblastomas and bone tumors as well.

4.  The change we observed in trends could have some biased result and might not be methodologically satisfactory enough which might be due to the increase number of admissions and more referrals to the hospital; however, as mentioned earlier the major role of malignant CNS tumors and SNS tumors in this increase cannot be fully explained and underestimated only with such justifications.

***Strengths***

1.  Despite the rarity of cancer in children, we assessed a considerable amount of childhood malignancies in a 15 year period, in one of the largest pediatric referral centers in Iran.

2.  All pathology records were kept well-organized at the pathology laboratory so all cases with uncertain diagnosis were excluded.

3.  The diagnosis was confirmed by two pediatric pathologists and special tests such as immunohistochemistry had been implemented when needed.

4.  As mentioned in the methods section, manual checks for duplicate records were performed by comparing names, age, gender, date of diagnosis, diagnosis and all duplicate cases whether due to recurrence or follow up, and they were excluded from the study.

Conclusion
----------

Despite of all possible methodological difficulties due to the hospital-based nature of this study, the findings of changes in trend of some tumor categories can indicate a need for further research in higher level like provincial and national levels. In addition to evaluation of annual trends in our center, the gathered data can be used to do more accurate programs to control cancer and also to help the policy-makers with more evidence-based resource allocation, particularly at the hospital level. Finally, further detailed research on each tumor category is recommended and a more thorough follow-up study on survival, mortality and the survivors\' quality of life is highly encouraged.[](#f10-IJCP-05-093){ref-type="fig"}[](#f11-IJCP-05-093){ref-type="fig"}
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###### 

Distribution of different tumor categories in different age groups

  Classification             Age groups   Total                               
  -------------------------- ------------ -------- -------- -------- -------- -----
  CNS tumors                 Count        16       74       55       30       175
  \% within Classification   9.1%         42.3%    31.4%    17.1%    100.0%   
  \% within Age groups       17.6%        22.1%    24.0%    23.3%    22.3%    
  Lymphomas                  Count        3        36       87       60       186
  \% within Classification   1.6%         19.4%    46.8%    32.3%    100.0%   
  \% within Age groups       3.3%         10.7%    38.0%    46.5%    23.7%    
  SNS tumors                 Count        30       75       19       7        131
  \% within Classification   22.9%        57.3%    14.5%    5.3%     100.0%   
  \% within Age groups       33.0%        22.4%    8.3%     5.4%     16.7%    
  Bone tumors                Count        0        0        2        4        6
  \% within Classification   .0%          .0%      33.3%    66.7%    100.0%   
  \% within Age groups       .0%          .0%      .9%      3.1%     .8%      
  Liver tumors               Count        11       20       7        2        40
  \% within Classification   27.5%        50.0%    17.5%    5.0%     100.0%   
  \% within Age groups       12.1%        6.0%     3.1%     1.6%     5.1%     
  Kidney tumors              Count        11       50       22       1        84
  \% within Classification   13.1%        59.5%    26.2%    1.2%     100.0%   
  \% within Age groups       12.1%        14.9%    9.6%     .8%      10.7%    
  Soft tissue sarcomas       Count        12       37       27       8        84
  \% within Classification   14.3%        44.0%    32.1%    9.5%     100.0%   
  \% within Age groups       13.2%        11.0%    11.8%    6.2%     10.7%    
  Germ cell tumors           Count        4        31       4        5        44
  \% within Classification   9.1%         70.5%    9.1%     11.4%    100.0%   
  \% within Age groups       4.4%         9.3%     1.7%     3.9%     5.6%     
  Other tumors               Count        4        12       6        12       34
  \% within Classification   11.8%        35.3%    17.6%    35.3%    100.0%   
  \% within Age groups       4.4%         3.6%     2.6%     9.3%     4.3%     
  Total                      Count        91       335      229      129      784
  \% within Classification   11.6%        42.7%    29.2%    16.5%    100.0%   
  \% within Age groups       100.0%       100.0%   100.0%   100.0%   100.0%   

###### 

Distribution of different tumors in both sexes

  Classification             Sex     Total            
  -------------------------- ------- ------- -------- -----
  CNS tumors                 Count   77      98       175
  \% within Classification   44.0%   56.0%   100.0%   
  Lymphomas                  Count   43      143      186
  \% within Classification   23.1%   76.9%   100.0%   
  SNS tumors                 Count   66      65       131
  \% within Classification   50.4%   49.6%   100.0%   
  Bone tumors                Count   3       3        6
  \% within Classification   50.0%   50.0%   100.0%   
  Liver tumors               Count   16      24       40
  \% within Classification   40.0%   60.0%   100.0%   
  Kidney tumors              Count   31      53       84
  \% within Classification   36.9%   63.1%   100.0%   
  Soft tissue sarcomas       Count   42      42       84
  \% within Classification   50.0%   50.0%   100.0%   
  Germ cell tumors           Count   34      10       44
  \% within Classification   77.3%   22.7%   100.0%   
  Other tumors               Count   17      17       34
  \% within Classification   50.0%   50.0%   100.0%   
  Total                      Count   329     455      784
  \% within Classification   42.0%   58.0%   100.0%   
